feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Irlab Therapeutics Q3’20: Framsteg på bolagsnivå och i pipeline
Research Note
2020-11-11
11:33
Redeye ger en kommentar på Irlabs delårsrapport för det tredje kvartalet.
AH
Anders Hedlund
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans